REGENXBIO Inc.RGNXNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank58
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-85.42%
↑ 73% vs avg
Percentile
P58
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-316.25%
Historical baseline
PeriodValueYoY Change
TTM-85.42%+64.1%
2024-237.89%+10.4%
2023-265.36%-22.5%
2022-216.67%-701.1%
202136.05%+157.5%
2020-62.65%+75.6%
2019-256.40%-708.4%
201842.14%+106.0%
2017-704.31%+50.1%
2016-1411.99%-